Quotient Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
72
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$50M
- Investors
-
1
Quotient Therapeutics General Information
Description
Developer of a platform intended to create transformative therapeutics with naturally selected targets. The company uses four key steps to study human natural target selection phenotyping, isolation, genotyping, and computation, enabling clients to direct us towards the best path for drug development.
Contact Information
Website
www.quotient-tx.comCorporate Office
- 7th Floor 50 Broadway
- Suite 4
- London SW1H 0DB
- England, United Kingdom
Corporate Office
- 7th Floor 50 Broadway
- Suite 4
- London SW1H 0DB
- England, United Kingdom
Quotient Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 12-Apr-2022 | $50M | Completed | Generating Revenue |
Quotient Therapeutics Comparisons
Industry
Financing
Details
Quotient Therapeutics Competitors (28)
One of Quotient Therapeutics’s 28 competitors is Strand (Biotechnology), a Formerly VC-backed company based in Bangalore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Strand (Biotechnology) | Formerly VC-backed | Bangalore, India | ||||
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| BioXcel | Corporation | Branford, CT | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| Macrogen Oceania | Corporation | Bella Vista, Australia |
Quotient Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Quotient Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quotient Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flagship Pioneering | Venture Capital | Minority |
Quotient Therapeutics FAQs
-
When was Quotient Therapeutics founded?
Quotient Therapeutics was founded in 2022.
-
Where is Quotient Therapeutics headquartered?
Quotient Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Quotient Therapeutics?
Quotient Therapeutics has 72 total employees.
-
What industry is Quotient Therapeutics in?
Quotient Therapeutics’s primary industry is Biotechnology.
-
Is Quotient Therapeutics a private or public company?
Quotient Therapeutics is a Private company.
-
What is Quotient Therapeutics’s current revenue?
The current revenue for Quotient Therapeutics is .
-
How much funding has Quotient Therapeutics raised over time?
Quotient Therapeutics has raised $50M.
-
Who are Quotient Therapeutics’s investors?
Flagship Pioneering has invested in Quotient Therapeutics.
-
Who are Quotient Therapeutics’s competitors?
Strand (Biotechnology), Sphere Fluidics, BioXcel, Deep Genomics, and Macrogen Oceania are some of the 28 competitors of Quotient Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
